Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer

This publication has 96 references indexed in Scilit:

• Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer
  Journal of Biological Chemistry, 2006
• Suppression of prostaglandin E2 receptor subtype EP2 by PPARγ ligands inhibits human lung carcinoma cell growth
  Biochemical and Biophysical Research Communications, 2004
• PGE₂‐mediated upregulation of iNOS in murine breast cancer cells through the activation of EP₄ receptors
  International Journal of Cancer, 2003
• Human colorectal adenomas demonstrate a size‐dependent increase in epithelial cyclooxygenase‐2 expression
  The Journal of Pathology, 2002
• Transcriptional Regulation of the Membrane-associated Prostaglandin E2 Synthase Gene
  Journal of Biological Chemistry, 2002
• Identification and Characterization of a Novel Type of Membrane-Associated Prostaglandin E Synthase
  Biochemical and Biophysical Research Communications, 2002
• Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin☆☆☆
  Gastroenterology, 1998
• Prostaglandin H Synthase Expression Is Variable in Human Colorectal Adenocarcinoma Cell Lines
  Experimental Cell Research, 1997
• Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
• Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.
  Gut, 1994